Repros Theraup (NASDAQ:RPRX)

CAPS Rating: 1 out of 5

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders.

Recs

0
Player Avatar SnowBawl (< 20) Submitted: 12/18/2012 7:36:10 AM : Outperform Start Price: $14.66 RPRX Score: -15.70

stockpickr 4 stocks jumping on big volume.

Report this Post Reply

Featured Broker Partners


Advertisement